The observation that right-sided CRC has a worse prognosis compared to the left-sided tumours has been described earlier, and KRAS and BRAF mutations have recently also been established as negative prognostic cancer markers [76,77]. This evidence concerns the gene KRAS and colorectal carcinoma.